Clinical Trial UCI-16-65

Title

A Phase 1 clinical trial to evaluate obinutuzumab with high-dose ibrutinib for the treatment of patients with chronic lymphocytic leukemia with progressive disease on single agent ibrutinib

Principal Investigator

Deepa Jeyakumar

Details

Learn More

For more information about cancer clinical trials at the Chao Family Comprehensive Cancer Center, please call toll-free: 877.UC.STUDY (877.827.8839) or email ucstudy@uci.edu